---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-23-002890"
form_type: "8-K"
ticker: "JYNT"
cik: "0001612630"
company_name: "JOINT Corp"
filed_at: "2023-05-04T23:59:59+00:00"
generated_at: "2026-06-15T22:06:19.388482+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Joint Corp Q1 revenue up 27% to $28.5M; net income $2.3M includes $3.9M ERC credits

## Summary
- Revenue $28.5M (+27% YoY); system-wide sales $115.4M (+17%); system-wide comp sales +8%.
- Operating loss $678K vs loss $176K YoY; net income $2.3M ($0.15 diluted) vs net loss $206K, includes $3.9M ERC.
- Adjusted EBITDA $2.0M vs $1.8M; clinic count 870 (740 franchised, 130 co-owned), up 32 from Dec 2022.
- 2023 guidance reaffirmed: revenue $123-128M, Adj. EBITDA $12.5-14.0M, franchised openings 100-120, co-owned greenfield 8-12.
- Opened greenfield clinic at Fort Dix in April; fourth with Army & Air Force Exchange Service.

## SEC filing metadata
- accession: 0001171843-23-002890
- form_type: 8-K
- ticker: JYNT
- cik: 0001612630
- company_name: JOINT Corp
- filed_at: 2023-05-04T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1612630/000117184323002890/0001171843-23-002890-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1612630/000117184323002890/f8k_050423.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-23-002890
- JSON: https://secwatch.observer/filing/0001171843-23-002890.json
- Plain text: https://secwatch.observer/filing/0001171843-23-002890.txt

## Key facts
- Earnings Releases
  JOINT Corp reported the quarter ended March 31, 2023 results: revenue $28.5 million, net income $2.3 million, EPS $0.15 per diluted share. Guidance reaffirmed.
  - Period: the quarter ended March 31, 2023
  - Revenue: $28.5 million
  - Net income: $2.3 million
  - EPS: $0.15 per diluted share
  - Guidance: reaffirmed
  - Result: reported results
  source text: franchisor of chiropractic clinics, reported its financial results for the quarter ended March 31, 2023. Financial Highlights: Q1 2023 Compared to Q1 2022 Grew revenue 27% to $28.5 million. Reported operating loss of $678,000, compared to a loss of $176,000. Reported net income of $2.3 million, including $3.9 million of employee retention credits, compared to a net
  evidence_url: https://www.sec.gov/Archives/edgar/data/1612630/000117184323002890/0001171843-23-002890-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.